Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.

Jin Y, Wang J, Ye X, Su Y, Yu G, Yang Q, Liu W, Yu W, Cai J, Chen X, Liang Y, Chen Y, Wong BH, Fu X, Sun H.

Br J Cancer. 2016 Mar 1;114(5):532-44. doi: 10.1038/bjc.2015.348. Epub 2016 Feb 23.

2.

Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.

Mirus JE, Zhang Y, Hollingsworth MA, Solan JL, Lampe PD, Hingorani SR.

Mol Cell Proteomics. 2014 Dec;13(12):3484-96. doi: 10.1074/mcp.M113.036517. Epub 2014 Sep 15.

3.

Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform.

Letarte S, Brusniak MY, Campbell D, Eddes J, Kemp CJ, Lau H, Mueller L, Schmidt A, Shannon P, Kelly-Spratt KS, Vitek O, Zhang H, Aebersold R, Watts JD.

Clin Proteomics. 2008 Dec 1;4(3-4):105.

4.

Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

Scott LC, Evans TR, Cassidy J, Harden S, Paul J, Ullah R, O'Brien V, Brown R.

Br J Cancer. 2009 Aug 4;101(3):410-7. doi: 10.1038/sj.bjc.6605175. Epub 2009 Jul 14.

5.

An insight into high-resolution mass-spectrometry data.

Eckel-Passow JE, Oberg AL, Therneau TM, Bergen HR 3rd.

Biostatistics. 2009 Jul;10(3):481-500. doi: 10.1093/biostatistics/kxp006. Epub 2009 Mar 26.

6.

Challenges and solutions in proteomics.

Hongzhan H, Shukla HD, Cathy W, Satya S.

Curr Genomics. 2007 Mar;8(1):21-8.

Supplemental Content

Support Center